Alexis Weston

This inventor holds 7 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Stingray Therapeutics, Inc., University of Utah Research Foundation. Active years: 2020-2026.

USPTO Granted Patents = 7 (Patent Applications = 4)

% Patents Active = 85.7

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

7 out of 7

Stingray Therapeutics, Inc.

patents

1 out of 1,685

University of Utah Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741963 - Imidazole compounds as inhibitors of ENPP1 (2026-09-22),

2. 12653835 - Phosphonates as inhibitors of ENPP1 and CDNP (2026-06-16),

3. 12152015 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2024-11-26),

4. 11591313 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2023-02-28),

5. 11407729 - Quinoline and quinazoline compounds and methods of use thereof (2022-08-09),

6. 11142524 - Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2021-10-12),

7. 10689376 - Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2020-06-23),

Title: Innovations and Contributions of Inventor Alexis Weston

Introduction

Alexis Weston is a prominent inventor based in Phoenix, AZ, known for her significant contributions to the field of therapeutic agents. With a total of five patents to her name, she has made remarkable strides in the development of compounds aimed at treating various diseases.

Latest Patents

Weston's latest patents include innovative inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). These patents focus on compounds and methods for their preparation and use as therapeutic or prophylactic agents, particularly for the treatment of cancer, bacterial, or viral diseases by targeting ENPP1.

Career Highlights

Throughout her career, Alexis Weston has worked with notable organizations such as Stingray Therapeutics, Inc. and the University of Utah Research Foundation. Her work has been instrumental in advancing research and development in her field.

Collaborations

Some of her notable coworkers include Sunil Sharma and Mohan Rao Kaadige, who have collaborated with her on various projects.

Conclusion

Alexis Weston continues to be a driving force in the innovation of therapeutic agents, contributing valuable knowledge and advancements in the medical field. Her work exemplifies the impact of dedicated inventors on healthcare solutions.